(Q41699273)

English

Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort

scientific article published on 15 October 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

expanded access

1 reference

based on heuristic

inferred from title

extensively drug-resistant tuberculosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Lorenzo Guglielmetti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Nicolas Veziris

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Damien Le Dû

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Mathilde Jachym

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Benoît Henry

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Diane Martin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Eric Caumes

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Nathalie Métivier

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

0 references

publication date

15 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

60

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

188-194

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Linezolid in the treatment of multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU786

21 January 2018

Identifiers

10.1093/CID/CIU786

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25320286%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41699273&oldid=1926049479"